» Articles » PMID: 40059157

Recent Advances and Challenges in Metal-based Antimicrobial Materials: a Review of Strategies to Combat Antibiotic Resistance

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2025 Mar 10
PMID 40059157
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the availability of a series of classical antibiotic drugs, bacterial infections continue to represent a significant and urgent threat to global human health. The emergence of drug-resistant bacteria and the slow pace of antibiotic development have rendered current treatment methods inadequate in meeting the clinical demands of bacterial infections. Consequently, there is an increasingly urgent and vital need for the development of safe, efficient, and alternative novel antimicrobial agents in the medical and healthcare field. Over the past five years, there has been a notable expansion in the field of nanomedicine with regard to the prevention and control of infectious diseases. The objective of this article is to provide a comprehensive review of the latest research developments in the field of metal nanomaterials for medical antimicrobial therapy. We begin by delineating the gravity of the bacterial infection crisis, subsequently undertaking a comprehensive examination of the potential mechanisms through which nanoparticles may combat bacterial infections and the specific applications of these nanomaterials in the treatment of diverse infectious diseases. In conclusion, we eagerly anticipate the future development directions of metal nanomaterials in the field of antimicrobial therapy. We believe that with continuous technological advancements and innovations, this field will make even more outstanding contributions to safeguarding human health and well-being.

References
1.
Li J, Zhang K, Ruan L, Chin S, Wickramasinghe N, Liu H . Block Copolymer Nanoparticles Remove Biofilms of Drug-Resistant Gram-Positive Bacteria by Nanoscale Bacterial Debridement. Nano Lett. 2018; 18(7):4180-4187. DOI: 10.1021/acs.nanolett.8b01000. View

2.
Zheng L, Li J, Yu M, Jia W, Duan S, Cao D . Molecular Sizes and Antibacterial Performance Relationships of Flexible Ionic Liquid Derivatives. J Am Chem Soc. 2020; 142(47):20257-20269. DOI: 10.1021/jacs.0c10771. View

3.
Fluksman A, Lafuente A, Braunstein R, Steinberg E, Friedman N, Yekhin Z . Modular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities. ACS Appl Mater Interfaces. 2023; 15(43):50330-50343. PMC: 10623511. DOI: 10.1021/acsami.3c07188. View

4.
Martinez-Bond E, Soriano B, Williams A . The mechanistic landscape of Lytic transglycosylase as targets for antibacterial therapy. Curr Opin Struct Biol. 2022; 77:102480. DOI: 10.1016/j.sbi.2022.102480. View

5.
Wang Z, Koirala B, Hernandez Y, Zimmerman M, Park S, Perlin D . A naturally inspired antibiotic to target multidrug-resistant pathogens. Nature. 2022; 601(7894):606-611. PMC: 10321319. DOI: 10.1038/s41586-021-04264-x. View